CareFusion Signs Exclusive Distribution Agreement With Breas Medical

CareFusion Will Become Exclusive Distributor in the U.S. for Vivo Line of Ventilators

Feb 09, 2015, 08:55 ET from CareFusion

SAN DIEGO, Feb. 9, 2015 /PRNewswire/ -- CareFusion (NYSE: CFN), a leading global medical technology company, today announced it has signed an exclusive distribution agreement for the U.S. with Breas Medical for their Vivo line of ventilation equipment.

Under the terms of the agreement, CareFusion will be the exclusive U.S. distributor for the Vivo by Breas® line of life support and bi-level ventilators from Breas Medical, including the Vivo 50, Vivo 40 and Vivo 30. The Vivo product line is designed for home mechanical ventilation and complements CareFusion's other ventilator products such as the AVEA®, VELA®, 3100A and 3100B HFOV, Infant Flow® SiPAP, ReVel® and LTV® Series ventilators. The combination of CareFusion and Breas Medical ventilation solutions allows CareFusion to provide customers a complete range of ventilation products.

"CareFusion is committed to providing single-vendor solutions that enable care providers and health systems to partner with us to meet their patients' ventilation needs across the acuity continuum," said Kevin Ketzel, senior vice president and general manager of Respiratory Technologies for CareFusion.  "Home ventilation is a critical need for many patients, and offering the Breas Medical Vivo line of home ventilators will provide additional choice for our customers. Breas Medical shares our commitment to innovation and high-quality products that help improve patients' lives."

Nicke Svanvik, CEO of Breas Medical added, "CareFusion is a great partner for the Breas Vivo brand. They have the scale, infrastructure, reputation, clinical experience and complementary product portfolio to make Breas's Vivo products a market leader in the United States. We are happy that CareFusion recognized the quality, robustness, innovation and design quality of our Vivo products."

The distribution agreement may be expanded with additional products and territories in the future. Financial terms of the agreement were not disclosed.  

About CareFusion Corporation
CareFusion (NYSE: CFN) is a global corporation serving the health care industry with products and services that help hospitals measurably improve the safety and quality of care. The company develops industry-leading technologies including Alaris® infusion pumps and IV sets, MaxPlus® and MaxZero IV connectors and sets, Pyxis® automated dispensing and patient identification systems, AVEA®, LTV® series and AirLife® ventilation and respiratory products, ChloraPrep® products, MedMined® services for data mining surveillance, V. Mueller® surgical instruments, and an extensive line of products that support interventional medicine. CareFusion employs more than 16,000 people across its global operations. More information may be found at www.carefusion.com.

About Breas Medical
Breas Medical is a leading manufacturer of innovative respiratory ventilators and sleep apnea products for the global home healthcare market.  Breas and its affiliates offer a broad range of patient-focused respiratory devices including Vivo™, Z1™, Z1Auto™, Nippy®, Clearway, and iSLEEP™ brands.  Products are sold in over 40 countries.  Breas Medical is a PBM Capital Group portfolio company and was acquired from GE Healthcare in February 2014. For more information, please visit www.breas.com.  

 

SOURCE CareFusion



RELATED LINKS

http://www.carefusion.com